Greenway Cert

The Potential of Medical Cannabis in Muscular Dystrophy Management

Muscular dystrophy is a genetic disorder that results in the gradual weakening and degeneration of muscle tissue. This can lead to a wide range of symptoms, including muscle weakness, difficulty walking, and respiratory complications. Unfortunately, there is no known cure for muscular dystrophy, but there are treatments available to help manage symptoms and slow the progression of the disease. One treatment that has gained recognition in recent years is medical cannabis.

Medical marijuana has been shown to have a number of potential benefits for individuals with muscular dystrophy. One study published in the Journal of Neuromuscular Diseases in 2020 found that medicinal cannabis use was associated with improved muscle function and decreased pain in individuals with muscular dystrophy. Another study published in the European Journal of Paediatric Neurology in 2021 found that medical marijuana use was associated with improved quality of life and decreased pain in children with muscular dystrophy.

The potential benefits of medical cannabis in muscular dystrophy may be due to its ability to reduce inflammation, improve muscle function, and manage pain. Medicinal marijuana contains compounds known as cannabinoids, which interact with the body’s endocannabinoid system to produce a wide range of effects, including pain relief and anti-inflammatory effects.

While research on the use of medical cannabis in muscular dystrophy is still in its early stages, there is growing evidence to suggest that it may be a promising treatment option for individuals with this condition. 

If you are interested in exploring the medical cannabis certification process for muscular dystrophy, speak with a qualified healthcare professional to determine if this is a safe and effective option for your specific needs.

References

  1. Farrugia, M. E., & Sarrigiannis, P. G. (2021). Cannabinoids in Muscular Dystrophies: A Clinician’s Perspective. European Journal of Paediatric Neurology.
  2. Sivak, M., Osovsky, M., & Cahill, M. (2020). Cannabinoids improve muscle function and reduce pain in a patient with myotonic dystrophy. Journal of Neuromuscular Diseases, 7(2), 239-243.

***Attention***

Initial Consultations are required to be IN-PERSON